Clinical Trials on Advanced/Metastatic Solid Tumors or Lymphomas
Total 3273 results
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Active, not recruitingAdvanced Solid TumorsChina
-
Prince of Songkla UniversityCompletedAdvanced Solid TumorsThailand
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Solid Tumors
-
AmgenCompleted
-
Georgetown UniversityWyeth is now a wholly owned subsidiary of PfizerCompletedAdvanced Solid TumorsUnited States
-
Silence Therapeutics GmbHCompleted
-
AstraZenecaWithdrawnCancer | Advanced Solid Tumours | Lymphomas
-
Aadi Bioscience, Inc.RecruitingAdvanced Solid Tumor | Tumor | Tumor, SolidUnited States
-
Institut CurieCompletedMetastatic and/or High Risk Solid Tumor of ChildrenFrance
-
Impact Therapeutics, Inc.RecruitingSolid Tumor | Advanced Solid TumorChina, Taiwan, United States, Australia
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Institut BergoniéBayerCompletedMetastatic Solid TumorsFrance
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Erasca, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, Canada, Korea, Republic of, United Kingdom, Australia
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
National Cancer Institute (NCI)Not yet recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced/Metastatic Solid MalignanciesUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
TopAlliance BiosciencesShanghai Junshi Bioscience Co., Ltd.; CTI Clinical Trial and Consulting ServicesRecruitingMetastatic Solid Tumor | Advanced Unresectable Solid TumorUnited States
-
BJ Bioscience, Inc.Active, not recruitingAdvanced Solid Tumor or LymphomaUnited States
-
Shandong New Time Pharmaceutical Co., LTDUnknownAdvanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin LymphomaChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMetastatic Solid TumorsUnited States, Spain, United Kingdom
-
Hadassah Medical OrganizationNovartisWithdrawnMetastatic Solid Tumors.Israel
-
Hadassah Medical OrganizationWithdrawnMetastatic Solid TumorsIsrael
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Deciphera Pharmaceuticals LLCRecruitingMelanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Pancreatic Ductal AdenocarcinomaUnited States
-
Pyxis Oncology, IncRecruiting
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Hansoh BioMedical R&D CompanyNot yet recruitingAdvanced Solid Tumors
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingAdvanced Solid TumorsChina
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingAdvanced Solid TumorsChina